Clinical Trial Update: Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates a vaccine therapy with or without interleukin-12 in patients with stage III/IV melanoma, including intraocular and cutaneous melano…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Interleukin-12 (interleukin-12)
• Vaccine therapy

Snippet

Sponsor: University of Southern California | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED